| A Clinical Trial of MK-1045 With Zilovertamab Vedotin in Participants With Diffuse Large B-cell Lymphoma (MK-1045-010) | Valacyclovir, Acyclovir | Phase 2 / Phase 3 | Not yet recruiting | Merck Sharp & Dohme LLC | Nov 5, 2026 |
| Study to Compare GS-1179 Versus Valacyclovir in HSV-2 Seropositive Participants With Recurrent Genital Herpes | Valacyclovir, Acyclovir | Phase 2 | Not yet recruiting | Gilead Sciences | Nov 3, 2026 |
| Intralesional Acyclovir Versus Intralesional Zinc Sulphate in the Treatment of Plantar Warts | Acyclovir | Phase 3 | Not yet recruiting | Assiut University | Sep 29, 2026 |
| CMV-CMI in csCMVi After HSCT | Foscarnet, Valganciclovir, Ganciclovir | — | Recruiting | The First Affiliated Hospital of Soochow University | Jul 7, 2026 |
| Efficacy and Safety of Oral Antiviral Therapy for Idiopathic Trigeminal Neuralgia | Acyclovir | Not applicable | Not yet recruiting | Beijing Tiantan Hospital | Jun 29, 2026 |
| Aglatimagene Besadenovec + Prodrug and Pembrolizumab vs Docetaxel for Stage IV Non-Squamous NSCLC Progressing on Pembrolizumab (AURORA) | Valacyclovir, Acyclovir | Phase 3 | Recruiting | Candel Therapeutics, Inc. | Jun 22, 2026 |
| SARS-CoV-2 and Herpesvirus Inhibition for Ending Long COVID Dysfunction | Valacyclovir, Acyclovir | Phase 2 | Recruiting | Icahn School of Medicine at Mount Sinai | May 19, 2026 |
| Letermovir vs Valganciclovir in CMV R+ Kidney Transplant | Valganciclovir | Phase 4 | Not yet recruiting | Elisabeth Kincaide | May 6, 2026 |
| Cord Blood Transplantation in Children and Young Adults With Blood Cancer | Vidarabine | Phase 2 | Recruiting | Memorial Sloan Kettering Cancer Center | May 5, 2026 |
| Efficacy of Electroacupuncture for Acute Herpes Zoster-Associated Pain and Biomarker Evaluation | Valacyclovir, Acyclovir | Not applicable | Recruiting | Dexiong Han | Apr 7, 2026 |
| Systemic and Topical Antiviral Control of Cytomegalovirus Anterior Uveitis: Treatment Outcomes - Trials I and II | Valganciclovir, Acyclovir, Ganciclovir | Phase 2 | Not yet recruiting | University of California, San Francisco | Apr 7, 2026 |
| HOME-PE2 : Home Treatment Versus Hospitalization in Patients With Acute Pulmonary Embolism, no Clinical Severity Criteria, and Either Right Ventricular Dysfunction or Elevated Troponin: a Randomized Controlled Trial | Penciclovir | Not applicable | Not yet recruiting | University Hospital, Angers | Apr 1, 2026 |
| A Multicenter, Randomized, Open-Label Study of Haplo-Cord HSCT for the Treatment of Aplastic Anemia | Ganciclovir | Not applicable | Recruiting | The First Affiliated Hospital of Soochow University | Mar 30, 2026 |
| Letermovir Prophylaxis in Children With EBV-Positive T/NK-Cell Lymphoproliferative Disease and Refractory/Relapsed EBV-Associated Hemophagocytic Lymphohistiocytosis | Foscarnet, Ganciclovir | Not applicable | Recruiting | Beijing Children's Hospital | Mar 23, 2026 |
| Evaluation of Long-term Efficacy of 4 to 6-month Course Antiviral Therapy for Neurodevelopmental Impairments Caused by Congenital Cytomegalovirus Infection | Valganciclovir, Ganciclovir | Phase 4 | Not yet recruiting | Hu Bofei | Mar 4, 2026 |
| Valganciclovir Prophylaxis Versus Preemptive Therapy for Cytomegalovirus in Living Donor Kidney Transplant Recipients | Valganciclovir | Phase 4 | Active, not recruiting | University of Guadalajara | Feb 24, 2026 |
| A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT | Cidofovir anhydrous | Phase 3 | Recruiting | SymBio Pharmaceuticals | Feb 4, 2026 |
| Trial to Study Anti- HCMV Therapy in Breast Cancer Patients With Progressive Intracranial Metastases and CMV Infection | Valganciclovir, Ganciclovir | Phase 2 | Recruiting | The Methodist Hospital Research Institute | Feb 3, 2026 |
| ValgaNciclovIR for CMV Viraemia in AdvaNced HIV diseAse | Valganciclovir, Ganciclovir | Phase 2 | Not yet recruiting | Wits Health Consortium (Pty) Ltd | Jan 30, 2026 |
| Oral Herpesviruses and Oral Mucositis in Patients Receiving Head and Neck Radiotherapy | Valacyclovir | Phase 2 | Enrolling by invitation | Instituto Oncoclinicas | Jan 23, 2026 |
| Study of an AAV Mediated Dual-Payload Gene Therapy in Patients With High Grade Glioma | Valacyclovir | Phase 1 / Phase 2 | Recruiting | Trogenix ltd | Jan 16, 2026 |
| Efficacy and Safety of Intravenous Dexamethasone Palmitate Treatments in Acute and Subacute Herpes Zoster Pain | Famciclovir | Not applicable | Not yet recruiting | Beijing Tiantan Hospital | Jan 15, 2026 |
| A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec | Valacyclovir | Phase 2 | Recruiting | Candel Therapeutics, Inc. | Jan 12, 2026 |
| Is Valacyclovir Non-inferior to Valganciclovir as CMV and EBV Prophylaxis in Kidney Transplant Recipients? A Single-Center Prospective Randomized Pilot Study | Valganciclovir, Ganciclovir | Not applicable | Recruiting | National Taiwan University Hospital | Dec 19, 2025 |
| Efficacy and Safety of Brivudine in the Treatment of Herpes Zoster | Famciclovir | Phase 4 | Recruiting | Peking University Third Hospital | Aug 1, 2025 |
| Multimodal Nerve Block and Pulse Radiofrequency for Acute Herpes Zoster Pain | Famciclovir | Not applicable | Not yet recruiting | Xiaguang Duan | Jan 29, 2025 |
| Effect of Mechanical Ventilation on Radiofrequency Ablation in Atrial Fibrillation | Famciclovir | — | Recruiting | Kocaeli City Hospital | Jan 24, 2025 |
| A Study of LIVTENCITY (Maribavir) in Adults With Cytomegalovirus (CMV) Infection After Transplantation in South Korea | Foscarnet, Cidofovir anhydrous | — | Recruiting | Takeda | Aug 15, 2024 |
| A Reduced-Intensity Conditioning Regimen (Cyclophosphamide, Pentostatin, Anti-thymocyte Globulin) Followed by Haploidentical Hematopoietic Stem Cell Transplant for the Treatment of Patients With Refractory or Recurrent Severe Aplastic Anemia | Vidarabine | Phase 1 | Recruiting | City of Hope Medical Center | Mar 7, 2023 |
| Study for Subjects With Relapsed/Refractory Non- Hodgkin Lymphoma | Vidarabine | Phase 1 | Recruiting | ImmunityBio, Inc. | Nov 16, 2022 |
| Evaluate the Safety of UF-KURE19 Cells in Non-Hodgkin Lymphomas | Vidarabine | Phase 1 | Active, not recruiting | David Wald | Jun 1, 2022 |
| Total Body Irradiation and Astatine-211-Labeled BC8-B10 Monoclonal Antibody for the Treatment of Nonmalignant Diseases | Vidarabine | Phase 1 / Phase 2 | Recruiting | Fred Hutchinson Cancer Center | Sep 10, 2019 |
| Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant | Vidarabine | Phase 2 | Active, not recruiting | Fred Hutchinson Cancer Center | Dec 19, 2018 |
| Pharmacokinetics of Drugs Administered to Children | Foscarnet | — | Recruiting | Duke University | Mar 29, 2018 |
| International Randomised Phase III Clinical Trial in Children With Acute Myeloid Leukaemia | Vidarabine | Phase 3 | Active, not recruiting | University of Birmingham | Mar 31, 2016 |
| Cidofovir Versus Best Supportive Care for Hemorrhagic Cystitis | Cidofovir anhydrous | Phase 2 | Active, not recruiting | M.D. Anderson Cancer Center | Feb 14, 2011 |
| Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant | Foscarnet | — | Active, not recruiting | City of Hope Medical Center | Sep 13, 2010 |